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Summary
Background Asthma is a chronic inflammatory disorder in which Th2, Th1 and suppressive T
cells (Tregs) play a role. The transcription factor FoxP3 plays a role in Treg differentiation
while T-bet is important for Th1 and GATA-3 for Th2 differentiation from naı¨ve T cells. Recent
data show that age-related deregulation of Treg cells is a mechanism of senescence affecting
several chronic diseases. It is crucial to understand the behaviour of these cell populations in
asthma for elderly patients.
Objective To evaluate FoxP3, GATA-3 and T-bet gene expression under basal conditions and
after in vitro activation in a group of elderly asthmatic compared with age-matched healthy
individuals.
Methods Thirty-two elderly asthmatics and 17 healthy elderly individuals were selected.
Serum total IgE was measured, and peripheral blood mononuclear cells (PBMCs) were isolated
and stimulated in vitro with anti-CD3/anti-CD28, followed by mRNA isolation. After reverse
transcription, real-time quantitative PCR was performed and relative quantification was
determined 2DDCt (2DDCt method).
Results The mean values and standard deviation of FoxP3, GATA-3 and T-bet relative
expression for control vs. asthma were 10.26.8 vs. 4.83.8, 2.42.9 vs. 1.70.9 and
3.32.1 vs. 2.11.5, respectively. Healthy individuals showed significantly higher expression
of FoxP3 and T-bet; asthmatics had a lower T-bet/GATA-3 ratio, higher serum IgE and a
positive significant correlation between total IgE and GATA-3 expression.
Conclusion and clinical relevance Elderly asthmatic patients have lower FoxP3 mRNA
expression in PBMC, which can be associated with the sustained inflammatory process and
with the decreased immune tolerance by Treg cells. The T-bet deficiency and the correlation of
GATA-3 expression with the increase of IgE are characteristics of long-lasting asthma.
Changes related to the immunosenescence process could provide an explanation for the minor
differences observed between the groups. It is important to clarify persistent modifications in
long-lasting asthma in the elderly and adequate future therapeutic approaches.
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Introduction
Asthma is an airway chronic inflammatory disorder
characterized by a decline in pulmonary function that is
correlated with age, disease duration and severity. As
more than 300 million individuals suffer from this disease
and the prevalence is increasing [1], it is an important
field of study. It is often reported in children but affects all
age groups including the elderly [1, 2]. In this age group,
this pathology represents a growing clinical problem, with
an estimated prevalence between 6% and 14%, and is
characterized by the same clinical features of the younger
population [3–6].
In asthmatic airways, Th2 cells are activated and release
several cytokines that regulate IgE production and
inflammatory cell recruitment, such as eosinophils [7].
Several studies addressed the role of Treg in allergic
diseases preventing disease development by suppressing
their activity such as Th2 cytokine production [8, 9]. Treg
has been defined by markers including CD4, CD25, and
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more recently, a member of the forkhead box transcription
factor – FoxP3 – was set as a more specific marker and is
also important for their development and function [10].
These cells have a suppressive effect on inflammatory
responses and are recognized as a major cell subset
maintaining peripheral immune tolerance [11–13]. FoxP3
is crucial for naı¨ve T cell differentiation towards the Treg
phenotype and is considered as the main regulator of
CD251 Treg cell activation [12, 14]. These cells prevent
both activation and effector function of autoreactive T
cells that escaped to other mechanisms of tolerance [13]
and they are assumed to control not only pathogenic Th2
cells but also Th1 cells. Although Th2 cells have been the
most frequently studied T cells in asthma, there is evi-
dence that Th1 cells are also involved in the development
of this disease. Moreover, Th2 and Th1 cells are regulated
and committed by the transcription factors GATA-3 and
T-bet, respectively.
Treg cells are essential in the regulation of inflamma-
tory diseases and more data are needed to clarify their role
in allergic diseases in addition to the established role of
Th1 and Th2 cells. During the ageing process, the immu-
noinflammatory response is modified and it is assumed
that in this age group peripheral blood (PB) Treg cells are
increased [5, 15].
The aim of this study was to evaluate fold increase of
FoxP3, GATA-3 and T-bet mRNA expression, in peripheral
blood mononuclear cells (PBMCs), under basal conditions
and following in vitro activation with anti-CD3/anti-
CD28, considering the ability of generated signals to
establish reciprocal modulation, in elderly asthmatic
patients. This study intends to clarify whether the decrease
on Treg cells reported in adult asthma persists in the
elderly aged groups despite the increased levels of Treg
cells inherent to the immunosenescence process.
Material and methods
Subjects and blood samples
This study enrolled 32 elderly (X65 years) (mean age
725 years) patients who had been suffering from asthma
for 430 years, after informed consent. All patients had
early-onset asthma starting at 2611 years. The diagnosis
and severity of asthma were defined according to guide-
lines of the Global Initiative for Asthma [1]. All patients
had asthma, controlled by using 250–750 mg of beclome-
tasone dipropionate daily and short-acting b2-agonists as
needed. All other anti-asthmatic drugs were withdrawn at
least 4 weeks before the study. The control group consisted
of healthy non-allergic elderly volunteers (n= 17) older
than 65 years (mean age 787 years). The absence of
allergic diseases and asthma in this control group was
confirmed on the basis of a detailed clinical questionnaire
and skin prick tests (SPT).
Smoking subjects and patients with recent (last 6 weeks)
infectious diseases, auto-immune diseases and neoplasic
diseases were excluded.
Lung function was assessed by spirometry (Vitalograph
Compact, Ennis, Ireland) at least 6 h after the last dose of any
bronchodilator. Predicted values of forced expiratory vo-
lume in 1 s (FEV1) were measured according to Knudson et
al. [16]. Fractional concentration of exhaled nitric oxide
(FENO) was measured using a NioxMino collection device
(Aerocrine, Solna, Sweden) with an expiratory flux of
50mL/s during 6 s, according to the American Thoracic
Society recommendations [17]. All the individuals studied
were subjected to SPT to 20 common aeroallergens (ALK-
ABELLO/Lancetter-tames Hollister Stier). Histamine dihy-
drochloride was used as a positive control (10mg/mL) and
saline solution used as a negative control. Subjects were
classified as allergic with one positive test associated with
clinical symptoms and as atopic if they had at least one
positive SPT.
The entire study was performed during January/Febru-
ary, outside the grass, weed and tree pollen season. In this
period, house dust mites’ growth and dispersion were also
restricted, which allowed a low allergen exposure and
clinical, stabilized condition.
PB was collected into serum and lithium–heparin
separating tubes.
IgE and eosinophils’ determination
Serum total IgE was measured using a commercial kit (Coat-
A-Counts Total-IgE IRMA, DPCs, Los Angeles, CA, USA)
based on an immune-radiometric assay of the solid phase
and according to the manufacturer’s guidelines. Concentra-
tion was determined by comparison with provided calibra-
tors. Haemograms were performed in order to count blood
eosinophils.
PBMC isolation and in vitro T cell stimulation
PBMCs were separated by gradient density using Biocoll
(1.077 g/mL) (Biochrom AG, Berlin, Germany) from
lithium–heparin tubes and 3106 PBMCs per well (24-
well plate) were stimulated in vitro (48 h, 37 1C and 5%
CO2), in an AIM-V serum-free medium (Gibco Brl, Invitro-
gen, Carlsbad, CA, USA) with 1 mg/mL of LPS-free anti-
CD3/anti-CD28 (granted from Swiss Institute of Allergy
and Asthma Research, SIAF, Davos, Switzerland), also
setting a control without antibodies (basal condition).
mRNA isolation and reverse transcription reaction
mRNA isolation was carried out according to the Qiagen-
RNeasy protocol (Qiagen, Valencia, CA, USA) and stored at
80 1C. RT-PCR was performed with 1 mg RNA tran-
scribed into cDNA with random hexamers and moloney
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murine leukaemia virus reverse transcriptase (all from
Fermentas GmbH, St. Leon-Rot, Germany). The reactions
were performed in a Thermocycler (Mycycler, BioRad,
Hercules, CA, USA) using the following steps: 10min at
25 1C, 60min at 42 1C, 10min at 70 1C and a final hold at
4 1C.cDNAwerestoredat80 1Cforno longer than2weeks.
Real-time PCR
cDNA was amplified using Sybergreen mix according to the
manufacturer’s recommendations, on a 96-well PCR plate,
and run on an IQ5 Real-Time PCR Detection System (all
reagents and systems from BioRad). The following sequence
of primers was referenced by SIAF: T-bet fwd GATGCGCCA
GGAAGTTTCAT, T-bet rev GCACAATCATCTGGGTCACATT;
GATA-3 fwd GCGGGCTCTATCACAAAATGA, GATA-3 rev
GCTCTCCTGGCTGCAGACAGC; FoxP3 fwd GAAACAGCAC
ATTCCCAGAGTTC, FoxP3 rev ATGGCCCAGCGGATGAG;
elongation factor-1 (EF-1) fwd CTGAACCATCCAGGCCAAAT,
EF-1 rev GCCGTGTGGCAATCCAAT.
Real-time PCR conditions were as follows: stage 1: 2min
at 50 1C; stage 2: 3min at 95 1C; stage 3: 15 s at 95 1C and
45 s at 60 1C (40 repeats).
The amount of FoxP3, GATA-3 and T-bet mRNA expres-
sion was normalized with endogenous control EF-1
(DCt values) and the relative quantification and calculation
of range of confidence were performed using the com-
parative threshold cycle (2DDCt ) method (relative gene
expression), as described by Livak and Schmittgen [18]. All
amplifications were carried out at least in duplicate.
Statistical analysis
Statistical analysis was performed using the SPSS 12.0
software package. Data were analysed using either ANOVA
(performing the Tukey HSD post hoc tests), Student’s t-test
(normality test passed with Kolmogorov–Smirnov) or the
Mann–Whitney non-parametric test (normality test
failed). Pearson correlation analysis was also performed
between the variables studied. Significance was defined
for P-valueo0.05.
Results
Twenty-two asthmatic patients presented positive SPTs to
at least one of the common aeroallergens tested and were
classified as allergic. Asthmatics presented normal mean
percentual values of FEV1 (9023), and in five indivi-
duals, these values were below 60% in accordance with a
diagnosis of severe asthma. Within the asthmatic group,
six patients presented high FENO values.
Age, sex, lung function, serum total IgE, blood eosino-
phils and FENO from elderly asthmatic patients and
healthy non-allergic non-asthmatic elderly volunteers
are summarized in Table 1. Allergic patients presented
higher serum IgE values and blood eosinophil counts and
the differences observed between allergic and non-aller-
gic, for serum total IgE, were statistically significant.
The FoxP3 and GATA-3 DCt values under basal condi-
tions were reduced in asthmatic patients when compared
with the control group, while the T-bet DCt values were
similar in both the groups studied (Fig. 1). Comparing the
studied groups for FoxP3, GATA-3 and T-bet relative gene
expression after in vitro stimulation, higher values (fold
increase averagestandard deviation) were observed in
controls (healthy individuals) than in asthmatic patients
(10.26.8 vs. 4.83.8, 2.42.9 vs. 1.70.9 and 3.32.1
vs. 2.11.5, respectively). Asthmatics showed lower rela-
tive mRNA expression values of FoxP3 and T-bet. These
differences among groups were statistically significant
(Po0.05) (Figs 2a, c and d).
Subdividing the asthmatic group into non-allergic and
allergic patients, the main statistically significant differ-
ences were once more for FoxP3, with lower and similar
relative mRNA expression values in allergics (4.83.0)
and non-allergics (4.84.3), contrasting to higher values
in healthy individuals (10.26.8) (Po0.05) (Fig. 2b).
However, the GATA-3 and T-bet values were similar
without statistical significance when allergic and non-
allergic patients were considered and compared with the
control group (1.40.8 and 1.81.0 vs. 2.42.9, respec-
tively, for GATA-3; 1.91.5 and 2.21.6 vs. 3.32.1,
respectively, for T-bet).
Table 1. Population description
Allergic asthmatics
patients (n=22)
Non-allergic asthmatics
patients (n= 10) Controls (n=17)
Gender: female/male 15/7 6/4 10/7
Age (years; meanSD) 725 714 787
Serum total IgE (kU/L; meanSD) 313284^ 116101^ 66.738.1
Blood eosinophils (cells/mL; meanSD) 237223 168116 15488.9
Lung function FEV1 (L/min) (% mean predicted; meanSD) 9023.5 9021.1 102.824.0
FeNO (p.p.b.; meanSD) 25.722.2 29.228.3 20.114.3
Multiple comparisons were performed using ANOVA analysis and differences in P-values40.05 were considered significant.
^Po0.05.
FENO, fractional concentration of exhaled nitric oxide; FEV1, forced expiratory volume in the first second; p.p.b., parts per billion; SD, standard deviation.
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A positive correlation was found between total IgE and
GATA-3 expression with statistical significance (r= 0.382,
P = 0.041) in the asthmatic group (Fig. 3a). On the con-
trary, there was no correlation for the other transcription
factors (FoxP3 and T-bet) with IgE values (Figs 3b and c)
or other clinical features (data not shown).
Taking into account that increased levels of IgE produc-
tion are associated with higher GATA-3 gene expression and
lower T-bet gene expression, thus affecting the balance
between Th2 and Th1 cells, the T-bet/GATA-3 ratiowas also
assessed using values after stimulation. When ratios
between these investigated genes were analysed, statistical
differences were observed between asthmatics and controls
for the T-bet/GATA-3 ratio, with lower mean values in the
patient group (1.51.3) than in the controls (2.83.3)
(P= 0.038) (Fig. 4a). Considering that the balance between
Treg/Th effector cells can also regulate the degree of
inflammation in asthma, the Treg/Th2 ratio (FoxP3/GATA-
3) was used additionally (Fig. 4b). Asthmatic patients
presented a slightly reduced ratio (5.26.6) when compared
with healthy control subjects (8.86.9) (P40.05) (Fig. 4b).
Discussion
This study was carried out to evaluate Th1-, Th2- and Treg-
related lineage-specific gene expression, in long-lasting
asthma. Asthmatics tend to demonstrate a decline in FEV1,
which is related to the disease’s progression, but can also be
affected by both genetic and environmental factors [2, 19].
Most of the patients had controlled asthma with lung
function and FENO values within the normal range, despite
the long disease duration [1]. It was also ensured that the
healthy control subjects were free from atopy by perform-
ing SPTs despite the absence of symptoms.
Although IgE levels decrease with age, IgE-mediated
allergy can affect 75% of elderly asthmatics, suggesting
that the Th2 phenotype can still be dominant in this
group. Th2 cells and GATA-3 play an important role in
allergic inflammation and asthma, and induce IgE pro-
duction [19]. The asthmatic patients presented high levels
of total IgE (Table 1) when SPT was positive. On the
contrary, the T-bet gene expression and Th1 pattern,
along with the IFN-g production, are usually associated
with non-allergic asthmatics and healthy subjects.
Although eosinophil infiltration is the main feature of
both allergic and non-allergic asthma [7, 19], it is known
that the overproduction of Th2-type cytokines can reg-
ulate antigen-induced eosinophil survival, leading to an
increase of eosinophils in the allergic patients studied.
The values of GATA-3 gene expression of asthmatics
were low under basal conditions and remained low after in
vitro stimulation, in contrast to what was expected
according to data for younger asthmatic groups who
present an increase in GATA-3 expression [20]. The
normal process of GATA-3 expression after in vitro
stimulation is probably repressed in these patients, who
seem to maintain the ability to produce high levels of IgE.
The low grade chronic pro-inflammatory status in elderly
(inflamm-ageing) probably plays a role in the relative bias
towards Th2 immunity reported in senescence affecting
both patients and healthy individuals [21] and reducing
the differences in GATA-3 expression between the two
groups analysed both in basal and in activated states.
Nevertheless, a significant positive correlation was
demonstrated between total IgE and GATA-3 expression
(r= 0.382, P= 0.041) (Figs 1, 2c and 3a). This finding
emphasizes the close relationship between IgE and
GATA-3 expression and underlines the importance of this
transcription factor as an inductor of IL4/IgE production
even in elderly patients. A statistical difference between
asthmatics and controls for the T-bet/GATA-3 ratio (Th1/
Th2 ratio), with lower mean values in the patient group
(P= 0.038), was also observed (Fig. 4a), which also em-
phasizes the Th2 role in asthma, where these cells are
increased [19]. Therefore, the reduced ratio in Treg/Th2
cells observed can also contribute to the persistence of
inflammation in long-lasting asthma (Fig. 4b).
The T-bet values, after in vitro stimulation, were sig-
nificantly lower in asthmatics when compared with the
control group (Fig. 2d). When considering both allergic
and non-allergic groups, the GATA-3 and T-bet values
were slightly lower, without statistical significance, when
compared with the control groups. The atopic status does
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Fig. 1. FoxP3, T-bet and GATA-3 DCt values for asthma patients (n=32)
and healthy control (n= 17) groups. The results are for DCt under the
basal condition after elongation factor-1 (EF-1) normalization and
statistical significance is indicated by ^ (Po0.05) after performing
t-test analysis. FoxP3, T-bet and GATA-3 mean valuesstandard devia-
tion, control vs. asthma: 11.42.7 vs. 9.21.6, 6.71.2 vs. 6.11.1 and
8.62.1 vs. 6.82.0.
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not introduce any adjustment in elderly patients. In fact, a
decrease in the T-bet values has already been reported in
severe asthma associated with airway remodelling affect-
ing younger patients [19, 20]. In spite of this, we should
emphasize again that this study was performed in elderly
patients and the results should be interpreted considering
the changes related to the immunosenescence process.
Individuals aged 65 years or over present an age-asso-
ciated shift towards the Th2 cytokine profile, affecting the
typical atopic phenotype. Furthermore, in the elderly,
there is a decline in the naı¨ve strains while the sensitized
cells become predominant [22].
T cell activation was induced with anti-CD3/anti-CD28,
allowing naı¨ve cells to become activated and to receive
signals from other cells, which modulate the expression of
T-bet, GATA-3 and FoxP3 genes. Cytokine environments
induce a preferential expression of T-bet or GATA-3 and a
Th1 or a Th2 dominant response with the release of their
cytokines. The reduction of naı¨ve cells in the elderly can
explain the impaired development of these two differen-
tiated phenotypes [23]. It should not be ignored that these
results could be reinforced hypothetically with the mea-
surement of cytokine like IL-10, IL-4 or IL-13 in the
culture supernatant. However, it is now recognized that
IL-10 is produced by Th1, Th2, Th17 and Treg cells, while
Th1 can produce IL-13 [24]. These recent findings argue
for much more flexibility in cytokine production and
support the controversial usefulness of their determina-
tion [24, 25]. The Foxp3 transcription factor, which can
suppress the expression of T-bet and GATA-3 both with a
reciprocal role, modulates the immune response when
increased [14, 26]. Regulatory cells are supposed to reduce
inflammatory responses in several diseases, including
asthma. The Treg cell count is low in allergic patients and
some therapeutic approaches such as specific immu-
notherapy can restore their normal values [20, 27]. The
increased FoxP3 expression was relevant both in controls
and in asthmatics upon activation, even when the two
groups of patients were considered (Figs 2a and b), which
might explain the low expression of GATA-3 and T-bet
genes (Figs 2c and d). However, healthy individuals
showed significantly higher FoxP3 expression values
following activation when compared with asthmatics, as
demonstrated previously by Provoost et al. [28] in
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Fig. 2. FoxP3 (a and b), GATA-3 (c) and T-bet (d) relative gene expression levels for asthma patients (n= 32) [non-allergic asthma (n= 10) and allergic asthma
(n= 22)] and healthy control (n= 17) groups. The results are expressed in fold increase (2DDCt ) comparing basal with activated conditions, and statistical
significance is indicated by ^ (Po0.05) after performing a t-test and ANOVA analysis. Box plot graphs display the median (line within the box) and
interquartile range (edge of the box). FoxP3, GATA-3 and T-bet fold increase mean valuesstandard deviation, control vs. asthma: 10.26.8 vs. 4.83.8,
2.42.9 vs. 1.70.9 and 3.32.1 vs. 2.11.5; and non-allergic asthma vs. allergic asthma for FoxP3: 4.84.3 vs. 4.83.0. Extreme values; 1outliers.
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younger groups. This lower value in asthmatics can
provide an explanation for the sustained inflammatory
process reported in long-lasting asthma.
The underlying chronic inflammatory state in the
elderly, with high circulatory pro-inflammatory cyto-
kines, is an additional stimulus for FoxP3 expression in
this age group, narrowing the difference between patients
and the healthy population.
Recent data demonstrate that the transcription factors
for Th1, Th2 and Th17 cells, GATA-3, T-bet, RORgt and
FoxP3, respectively, can be co-expressed in some Tregs
and exist in vivo [25]. Therefore, through this work, the
hypothesis that these Treg cells may become effector cells
and participate in normal immune response cannot be
excluded. A better understanding of the reciprocal mod-
ulation of these three cell phenotypes that control the
immunoinflammatory process is key in order to imple-
ment future therapeutic approaches.
In conclusion, efforts to improve asthma care and
reduce the mortality have evolved from an understanding
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Fig. 3. Significant correlation between GATA-3 and total serum IgE levels (kU/L) in patients with asthma (n= 28) (a, Spearman correlation test, r=0.382;
P=0.041). FoxP3 and T-bet relative gene expression values and total serum IgE levels (kU/L) in patients with asthma (n=28) without a correlation (b,
Spearman correlation test, r= 0.032; P= 0.871; c, Spearman correlation test, r= 0.133; P= 0.499). P-values were calculated after Pearson correlation analysis.
−1.00
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00(a) (b)
ControlsAsthma
Group
T-
be
t/G
AT
A-
3 
ra
tio
−4.00
−2.00
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
16.00
18.00
Controls
Asthma Media
Group
Fo
xP
3/
G
AT
A-
3 
ra
tio
♦
Fig. 4. Asthma (n= 32) and control (n= 17) group T-bet/GATA-3 ratio (a) and FoxP3/GATA-3 ratio (b). Bars show means [meanstandard deviation: (a)
1.51.3 vs. 2.83.3, P= 0.038 and (b) 5.26.6 vs. 8.86.9, P40.05]. P-values were calculated as a result of Student’s t-test analysis.
c 2010 Blackwell Publishing Ltd, Clinical & Experimental Allergy, 1–7
6 S. Vale Pereira et al
of the inflammatory basis of asthma. Older people with
asthma received low priority regarding research and
interventions. Treatments that ameliorate asthma symp-
toms, including immunotherapy and steroids, which
could restore Treg cell function, have deserved a better
attention in the scientific community. This study demon-
strates that elderly asthmatic patients also present a
reduction in Treg cells. In addition, despite their low
values of T-bet and GATA-3 expression, the ratio of
expression of these two transcription factors shows a T-
bet deficiency while GATA-3 expression increases in
parallel to the IgE value. An improved understanding of
the T cell network involved in long-lasting asthma
affecting elderly allows considering new therapeutic
approaches directed towards increasing FoxP31Treg and
decreasing GATA-3 cells also in elderly patients.
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